LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Bloodhound Technologies created a SaaS (Software as a Service) delivery platform aimed at helping healthcare payers control fraud and waste through a real-time claims processing environment.
Sold in 2011 to Verisk Analytics, Bloodhound customers included commercial health plans, state Medicaid agencies, and third-party administrators (TPAs) focused on combatting healthcare fraud through an emphasis on real-time adjudication, transparency for all participants in the claims cycle, business intelligence, and increased auto-adjudication and processing efficiencies.
Website
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.